Publications:

Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial.

Bmc Cancer

Miura, Satoru S; Koh, Yasuhiro Y; Azuma, Koichi K; Yoshioka, Hiroshige H; Koyama, Kenichi K; Teraoka, Shunsuke S; Ishii, Hidenobu H; Kibata, Kayoko K; Ozawa, Yuichi Y; Tokito, Takaaki T; Oyanagi, Jun J; Shimokawa, Toshio T; Kurata, Takayasu T; Yamamoto, Nobuyuki N; Tanaka, Hiroshi H

Publication Date: 2023-01-03

Variant appearance in text: EGFR: F795C

PubMed Link: 36597021

Variant Present in the following documents:

• Main text
• 12885_2022_Article_10467.pdf

View BVdb publication page

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort.

Experimental Hematology & Oncology

Fairclough, Stephen R SR; Kiedrowski, Lesli A LA; Lin, Jessica J JJ; Zelichov, Ori O; Tarcic, Gabi G; Stinchcombe, Thomas E TE; Odegaard, Justin I JI; Lanman, Richard B RB; Shaw, Alice T AT; Nagy, Rebecca J RJ

Publication Date: 2019

Variant appearance in text: EGFR: F795C

PubMed Link: 31632838

Variant Present in the following documents:

• Main text
• 40164_2019_Article_148.pdf

View BVdb publication page

Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature.

Lung Cancer (Auckland, N.Z.)

Klempner, Samuel J SJ; Mehta, Pareen P; Schrock, Alexa B AB; Ali, Siraj M SM; Ou, Sai-Hong Ignatius SI

Publication Date: 2017

Variant appearance in text: EGFR: F795C

PubMed Link: 29255376

Variant Present in the following documents:

• Main text
• lctt-8-241.pdf

View BVdb publication page

Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach.

The Oncologist

Kato, Shumei S; Kurasaki, Kellie K; Ikeda, Sadakatsu S; Kurzrock, Razelle R

Publication Date: 2018-02

Variant appearance in text: EGFR: F795C

PubMed Link: 29038235

Variant Present in the following documents:

• supp_the2017-0199_onco12285-sup-0001-suppinfo01.pdf

View BVdb publication page